RHODES JENNIFER J 1568249 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-08 | 2024-02-06 | 2024-02-06 | 4 | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | acq | 25889.0 | 100.0 | 1.58 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code A | 25889.0 | 164.18 (ACAD) |
| 2024-02-08 | 2024-02-06 | 2024-02-06 | 4 | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | acq | 126589.0 | 100.0 | 7.71 | 25.74 | Direct | Stock Option (Right To Buy) | ACADIA PHARMACEUTICALS INC | code A | 126589.0 | 164.18 (ACAD) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)